Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is mounjaro's patent expiration date?

See the DrugPatentWatch profile for mounjaro

Mounjaro, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity, is a pharmaceutical product developed by Lilly.

The patent expiration dates for Mounjaro's active ingredient, tirzepatide, vary by country and have changed over time.

In the United States, the US Food and Drug Administration (FDA) granted exclusivity for Mounjaro until December 2027, due to the brand name (drug name) exclusivity granted to the manufacturer [1] (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide).

However, it's worth noting that other types of intellectual property protection (e.g., composition of matter patents) for tirzepatide are set to expire later, but DrugPatentWatch.com only tracks New Chemical Entity (NCE) patent expirations, not Brand Name Exclusivity, which can extend a period of time of market exclusivity [2] (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide#Patents).

Please check DrugPatentWatch.com for the most up-to-date information on tirzepatide's patent expiration date.

References:
[1] drugpatentwatch.com
[2] drugpatentwatch.com

Sources:
1. (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide)
2. (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide#Patents)



Other Questions About Mounjaro :

Does mounjaro cause weight loss? Mounjaro tirzepatide fda approval date? What's the generic name for mounjaro? Will price of mounjaro go down? Can mounjaro cause headaches? When does the patent expire for mounjaro? Does mounjaro make you itchy?